Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
group_4_presentation_3_-_effects_of_marijuana_on_the_brain [2017/04/07 20:52] gillas3 |
group_4_presentation_3_-_effects_of_marijuana_on_the_brain [2018/01/25 15:18] (current) |
||
|---|---|---|---|
| Line 70: | Line 70: | ||
| In Canada, as in many other countries, marijuana is the most commonly used illicit drug (Statistics Canada, 2013). | In Canada, as in many other countries, marijuana is the most commonly used illicit drug (Statistics Canada, 2013). | ||
| - | <box 80% round | >{{:rsz_1231324reqwf.png|}} </box|Figure ##: Estimated prevalence (proportion) of cannabis dependence by age, sex and region, 2010. (Degenhard et al, 2013)> | + | <box 80% round | >{{:rsz_1231324reqwf.png|}} </box|Figure 2: Estimated prevalence (proportion) of cannabis dependence by age, sex and region, 2010. (Degenhard et al, 2013)> |
| Throughout the world the prevalence was higher in males than females, resulting in an average male:female sex ratio of 1.8 (Degenhard et al, 2013). Prevalence peaks worldwide in the 20-24 years age group at between and then steadily decreasing after that age group thereafter (Degenhard et al, 2013). | Throughout the world the prevalence was higher in males than females, resulting in an average male:female sex ratio of 1.8 (Degenhard et al, 2013). Prevalence peaks worldwide in the 20-24 years age group at between and then steadily decreasing after that age group thereafter (Degenhard et al, 2013). | ||
| - | <box 50% round | >{{:rsz_1journalpone0076635g002.png|}} </box|Figure ##: Pooled regional prevalence of cannabis dependence, 2010. | + | <box 50% round | >{{:rsz_1journalpone0076635g002.png|}} </box|Figure 3: Pooled regional prevalence of cannabis dependence, 2010. |
| Note. Prevalence estimates were standardised by population age and sex; AP-HI: Asia Pacific, High Income, As-C: Asia Central, AS-E: Asia East, AS-S: Asia South, A-SE: Asia Southeast, Aus: Australasia, Caribb: Caribbean, Eur-C: Europe Central, Eur-E: Europe Eastern, Eur-W: Europe Western, LA-An: Latin America, Andean, LA-C: Latin America, Central, LA-Sth: Latin America, Southern, LA-Trop: Latin America, Tropical, Nafr-ME: North Africa/Middle East, Nam-HI: North America, High Income, Oc: Oceania, SSA-C: Sub-Saharan Africa, Central, SSA-E: Sub-Saharan Africa, East, SSA-S: Sub-Saharan Africa Southern, SSA-W: Sub-Saharan Africa, West. (Degenhard et al, 2013)> | Note. Prevalence estimates were standardised by population age and sex; AP-HI: Asia Pacific, High Income, As-C: Asia Central, AS-E: Asia East, AS-S: Asia South, A-SE: Asia Southeast, Aus: Australasia, Caribb: Caribbean, Eur-C: Europe Central, Eur-E: Europe Eastern, Eur-W: Europe Western, LA-An: Latin America, Andean, LA-C: Latin America, Central, LA-Sth: Latin America, Southern, LA-Trop: Latin America, Tropical, Nafr-ME: North Africa/Middle East, Nam-HI: North America, High Income, Oc: Oceania, SSA-C: Sub-Saharan Africa, Central, SSA-E: Sub-Saharan Africa, East, SSA-S: Sub-Saharan Africa Southern, SSA-W: Sub-Saharan Africa, West. (Degenhard et al, 2013)> | ||
| Prevalence in high income regions was much higher than that in low to middle income regions and the global average (Degenhard et al, 2013). Cannabis dependence in Australasia is about 8 times higher than prevalence in Sub-Saharan Africa, West (Degenhard et al, 2013). | Prevalence in high income regions was much higher than that in low to middle income regions and the global average (Degenhard et al, 2013). Cannabis dependence in Australasia is about 8 times higher than prevalence in Sub-Saharan Africa, West (Degenhard et al, 2013). | ||
| - | <box 50% round | >{{:rsz_journalpone0076635g004.png|}}</box|Figure ##: Country-level DALYs per 100,000 population for cannabis dependence, age-standardised, for 2010. | + | <box 50% round | >{{:rsz_journalpone0076635g004.png|}}</box|Figure 4: Country-level DALYs per 100,000 population for cannabis dependence, age-standardised, for 2010. |
| Note. Low: shows countries with statistically lower DALY rates than global mean; Middle: Shows countries with DALY rates that are not statistically different to global mean; High: Shows countries with statistically higher DALY rates than global mean. (Degenhard et al, 2013)> | Note. Low: shows countries with statistically lower DALY rates than global mean; Middle: Shows countries with DALY rates that are not statistically different to global mean; High: Shows countries with statistically higher DALY rates than global mean. (Degenhard et al, 2013)> | ||
